DCM

DAFNA Capital Management Portfolio holdings

AUM $405M
1-Year Est. Return 24.52%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+24.52%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$99.1M
AUM Growth
-$6.37M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
65
New
Increased
Reduced
Closed

Top Buys

1
+$3.9M
2
+$3.01M
3
+$2.52M
4
CLVS
Clovis Oncology, Inc.
CLVS
+$1.67M
5
NBIX icon
Neurocrine Biosciences
NBIX
+$1.04M

Top Sells

1
+$4.42M
2
+$2.08M
3
+$1.47M
4
KERX
Keryx Biopharmaceuticals Inc
KERX
+$1.42M
5
GLMD icon
Galmed Pharmaceuticals
GLMD
+$766K

Sector Composition

1 Healthcare 55.76%
2 Financials 1.1%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
51
$208K 0.21%
10,000
52
$205K 0.21%
55,202
53
– –
0
54
– –
0
55
$74K 0.07%
+10,745
56
$58K 0.06%
20,000
57
– –
-12,142
58
– –
-25,000
59
– –
-66,344
60
– –
-92,400
61
– –
-3,333
62
– –
-12,017
1 2
3